Kidron Miriaminsider trades
In SEC Form 4 filings, Kidron Miriam is listed as Chief Scientific Officer of Oramed Pharmaceuticals Inc. (ORMP). Kidron Miriam reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 25.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ORMPOramed Pharmaceuticals Inc. | Chief Scientific Officer | 8 | Sep 25 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-25
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ORMPOramed Pharmaceuticals Inc. | Sep 24 | Sep 25 | A | 208,125 | not reported | not reported | 1,341,263 | No | Form 4 |
| ORMPOramed Pharmaceuticals Inc. | Sep 24 | Sep 25 | A | 209,291 | not reported | not reported | 1,550,554 | No | Form 4 |
| ORMPOramed Pharmaceuticals Inc. | Sep 24 | Sep 25 | D · derivative | 104,000 | $3.16 | $328,640 | not reported | No | Form 4 |
| ORMPOramed Pharmaceuticals Inc. | Sep 24 | Sep 25 | D · derivative | 100,000 | $4.80 | $480,000 | not reported | No | Form 4 |
| ORMPOramed Pharmaceuticals Inc. | Sep 24 | Sep 25 | D · derivative | 69,999 | $7.77 | $543,892 | not reported | No | Form 4 |
| ORMPOramed Pharmaceuticals Inc. | Sep 24 | Sep 25 | D · derivative | 47,000 | $8.14 | $382,580 | not reported | No | Form 4 |
| ORMPOramed Pharmaceuticals Inc. | Sep 24 | Sep 25 | D · derivative | 100,000 | $10.40 | $1,040,000 | not reported | No | Form 4 |
| ORMPOramed Pharmaceuticals Inc. | Sep 24 | Sep 25 | D · derivative | 72,000 | $13.89 | $1,000,080 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.